trending Market Intelligence /marketintelligence/en/news-insights/trending/_SslW3NIm4CrnzKEaX-Exg2 content esgSubNav
In This List

Ritter Pharmaceuticals falls out of Nasdaq compliance

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Ritter Pharmaceuticals falls out of Nasdaq compliance

Ritter Pharmaceuticals Inc. fell out of compliance with Nasdaq's $1 minimum bid price listing rule.

The Los Angeles-based developer of drugs to treat gastrointestinal diseases has until June 24, 2019, to regain compliance, with a possibility for extension.

The company plans to evaluate available options to address the deficiency and regain compliance with the rule, the company said in a filing.